Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Rachel E. Sanborn

Dr. Rachel E. Sanborn

Medical Oncologist

Dr. Rachel Sanborn handles pleural mesothelioma as the co-director of the Thoracic Oncology Program at the Providence Cancer Institute in Portland, Oregon.

Get in touch
Jump to a Topic:

About Rachel E. Sanborn

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Board Certified icon

    Board Certified in Medical Oncology

  • Research Excellence icon

    Excellence in Research

Sanders is part of an expert team of thoracic cancer specialists at Providence who guide patients through a program that includes screening, diagnostics, multidisciplinary treatment and monitoring. She makes sure all phases of care are covered.

While much of her time is spent with lung cancer patients, Sanborn also has a strong clinical interest in rare thoracic malignancies such as pleural mesothelioma, an aggressive cancer caused by asbestos exposure.

She also handles esophageal cancer, chest wall tumors, thymus cancer, tracheal cancer and endocrine complications of cancer therapy.

She has experience with plasma cell dyscrasia, mediastinal tumors and cancer during pregnancy.

Sanborn, who received her medical degree from Oregon Health & Science University, is the primary investigator in several clinical trials at Providence involving lung cancer.

Her approach to care involves the personalization of treatment, but often leads to more advantageous outcomes.

Close Bond with Patients

Sanborn works closely with the thoracic surgeons, radiologists and pulmonologists, making sure care for each patient is well-planned and coordinated.

“What I enjoy most about being a medical oncologist is the close bond I develop with a patient and his family as we work together through a very difficult process,” she said. “My job is to help them make decisions about a complicated illness, so that we can find what feels right for that patient, and making sure we are providing the very best care possible.”

She has written on promising developments in lung cancer screening and novel drug development that is being used today in lung cancer treatment.

The Providence Cancer Institute is part of a nonprofit network of care centers, clinics, hospitals, doctors and affiliated services started more than 150 years ago by Sisters of Providence.

Sanborn did her residency in internal medicine at the University of Illinois and returned to Portland for a fellowship in medical oncology and hematology at Oregon Health & Science University.

Disclaimer: Dr. Rachel E. Sanborn has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Providence Health & Services. (n.d.). Rachel E. Sanborn M.D.
    Retrieved from:
  2. Providence Health & Services. (n.d.). Clinical Trial Results. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 31, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now